-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Piper Sandler Downgrades Nevro to Underweight, Lowers Price Target to $38

Benzinga · 01/06/2023 05:10
Piper Sandler analyst Adam Maeder downgrades Nevro (NYSE:NVRO) from Neutral to Underweight and lowers the price target from $42 to $38.